S. L. Cessie

The type 2 deiodinase ORFa-Gly3Asp polymorphism (rs12885300) influences the set point of the hypothalamus-pituitary-thyroid axis in patients treated for differentiated thyroid carcinoma.

K. Heemstra, H. Hoftijzer, Theo J. Visser, 2011, The Journal of clinical endocrinology and metabolism.

A critical appraisal of pharmacogenetic inference

J W Jukema, R A J Smit, R Noordam, 2018, Clinical genetics.